Martin Cederlöf1, Ralf Kuja-Halkola2, Henrik Larsson3, Arvid Sjölander2, Per Östberg4, Sebastian Lundström5, Ian Kelleher6, Paul Lichtenstein2. 1. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden. Electronic address: Martin.Cederlof@ki.se. 2. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden. 3. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden; School of Medical Sciences, Örebro University, Örebro, Sweden. 4. Division of Speech and Language Pathology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Sweden. 5. Centre for Ethics, Law and Mental Health (CELAM), University of Gothenburg, Sweden; Gillberg Neuropsychiatry Centre, University of Gothenburg, Sweden. 6. Department of Psychiatry, Royal College of Surgeons in Ireland, Ireland.
Abstract
INTRODUCTION: Psychotic experiences are associated with later substance use disorder and suicidal behavior, but individual psychotic experiences have not been examined in a longitudinal data set. Also, the potential dose-response relationship between these phenomena remains unknown. METHOD: Cohort study including 9242 adolescents who participated in The Child and Adolescent Twin Study in Sweden (CATSS). At ages 15 and/or 18, seven psychotic experiences (auditory and visual hallucinations, and five delusions) were assessed via questionnaires. Outcomes at follow-up were physician-assigned diagnoses of substance use disorder and suicide attempts ascertained from the Swedish Patient Register. Associations were estimated with Cox regressions and expressed as hazard ratios. RESULTS: All psychotic experiences were associated with later substance use disorder and/or suicide attempts, with hazard ratios ranging from 1.6 to 3.0. A dose-response relationship was observed between psychotic experiences and later substance use disorder, and suicide attempt. DISCUSSION: Auditory and visual hallucinations as well as delusions in adolescence are associated with later development of substance use disorder and suicide attempt, and there is a dose-response relationship between the load of psychotic experiences and these adverse outcomes. Clinicians should assess subclinical hallucinations as well as delusions in psychiatric evaluations of adolescents.
INTRODUCTION:Psychotic experiences are associated with later substance use disorder and suicidal behavior, but individual psychotic experiences have not been examined in a longitudinal data set. Also, the potential dose-response relationship between these phenomena remains unknown. METHOD: Cohort study including 9242 adolescents who participated in The Child and Adolescent Twin Study in Sweden (CATSS). At ages 15 and/or 18, seven psychotic experiences (auditory and visual hallucinations, and five delusions) were assessed via questionnaires. Outcomes at follow-up were physician-assigned diagnoses of substance use disorder and suicide attempts ascertained from the Swedish Patient Register. Associations were estimated with Cox regressions and expressed as hazard ratios. RESULTS: All psychotic experiences were associated with later substance use disorder and/or suicide attempts, with hazard ratios ranging from 1.6 to 3.0. A dose-response relationship was observed between psychotic experiences and later substance use disorder, and suicide attempt. DISCUSSION: Auditory and visual hallucinations as well as delusions in adolescence are associated with later development of substance use disorder and suicide attempt, and there is a dose-response relationship between the load of psychotic experiences and these adverse outcomes. Clinicians should assess subclinical hallucinations as well as delusions in psychiatric evaluations of adolescents.
Authors: Jordan E DeVylder; Courtney Cogburn; Hans Y Oh; Deidre Anglin; Melissa Edmondson Smith; Tanya Sharpe; Hyun-Jin Jun; Jason Schiffman; Ellen Lukens; Bruce Link Journal: Schizophr Bull Date: 2017-09-01 Impact factor: 9.306
Authors: Nicole R Karcher; Mallory J Klaunig; Nourhan M Elsayed; Rita L Taylor; Samantha Y Jay; Jason Schiffman Journal: J Am Acad Child Adolesc Psychiatry Date: 2022-04-01 Impact factor: 13.113
Authors: Evelyn J Bromet; Matthew K Nock; Sukanta Saha; Carmen C W Lim; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Guilherme Borges; Ronny Bruffaerts; Louisa Degenhardt; Giovanni de Girolamo; Peter de Jonge; Silvia Florescu; Oye Gureje; Josep M Haro; Yanling He; Chiyi Hu; Elie G Karam; Viviane Kovess-Masfety; Sing Lee; Jean-Pierre Lepine; Zeina Mneimneh; Fernando Navarro-Mateu; Akin Ojagbemi; José Posada-Villa; Nancy A Sampson; Kate M Scott; Juan C Stagnaro; Maria C Viana; Miguel Xavier; Ronald C Kessler; John J McGrath Journal: JAMA Psychiatry Date: 2017-11-01 Impact factor: 21.596
Authors: Kim Maijer; Mark Hayward; Charles Fernyhough; Monica E Calkins; Martin Debbané; Renaud Jardri; Ian Kelleher; Andrea Raballo; Aikaterini Rammou; James G Scott; Ann K Shinn; Laura A Steenhuis; Daniel H Wolf; Agna A Bartels-Velthuis Journal: Schizophr Bull Date: 2019-02-01 Impact factor: 9.306
Authors: Oliver Pain; Frank Dudbridge; Alastair G Cardno; Daniel Freeman; Yi Lu; Sebastian Lundstrom; Paul Lichtenstein; Angelica Ronald Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2018-03-31 Impact factor: 3.568